https://londonkidney.ca/ 2026-04-14T05:12:37.710Z https://londonkidney.ca/trials 2026-04-14T05:12:37.710Z https://londonkidney.ca/team 2026-04-14T05:12:37.710Z https://londonkidney.ca/publications 2026-04-14T05:12:37.710Z https://londonkidney.ca/news 2026-04-14T05:12:37.710Z https://londonkidney.ca/updates 2026-04-14T05:12:37.710Z https://londonkidney.ca/contact 2026-04-14T05:12:37.710Z https://londonkidney.ca/training 2026-04-14T05:12:37.710Z https://londonkidney.ca/capabilities 2026-04-14T05:12:37.710Z https://londonkidney.ca/privacy 2026-04-14T05:12:37.710Z https://londonkidney.ca/accessibility 2026-04-14T05:12:37.710Z https://londonkidney.ca/llms.txt 2026-04-14T05:12:37.710Z https://londonkidney.ca/team/amit-garg 2026-04-12T16:02:09.000Z https://londonkidney.ca/team/susan-huang 2026-04-12T16:02:07.000Z https://londonkidney.ca/team/brad-urquhart 2026-04-12T16:02:10.000Z https://londonkidney.ca/team/danielle-nash 2026-04-12T16:02:15.000Z https://londonkidney.ca/team/andrea-cowan 2025-12-30T20:54:27.000Z https://londonkidney.ca/team/pavel-roshanov 2026-04-12T16:02:06.000Z https://londonkidney.ca/team/kyla-naylor 2025-12-30T20:59:23.000Z https://londonkidney.ca/team/lakshman-gunaratnam 2026-04-12T16:02:11.000Z https://londonkidney.ca/team/dervla-connaughton 2026-04-12T16:02:13.000Z https://londonkidney.ca/team/peter-blake 2025-12-30T20:59:19.000Z https://londonkidney.ca/team/andrew-house 2026-04-12T16:02:14.000Z https://londonkidney.ca/team/arsh-jain 2025-12-30T20:59:20.000Z https://londonkidney.ca/team/matthew-weir 2026-04-12T16:02:08.000Z https://londonkidney.ca/team/louise-moist 2026-04-12T16:02:12.000Z https://londonkidney.ca/team/christopher-mcintyre 2026-04-12T16:04:17.000Z https://londonkidney.ca/trials/bay3401016-biomarker-study-alport 2025-12-30T22:54:10.000Z https://londonkidney.ca/trials/combined-dose-finding-and-cv-outcomes-study-with-csl300-clazakizumab-in-adult-subjects-with-eskd 2025-12-30T20:54:16.000Z https://londonkidney.ca/trials/bleeding-reduction-in-acute-and-chronic-kidney-patients-having-surgery-brackets-pilot-trial 2025-12-30T22:54:25.000Z https://londonkidney.ca/trials/sodium-deposition-in-soft-tissues-of-patients-with-kidney-disease 2026-04-12T16:04:06.000Z https://londonkidney.ca/trials/personalized-medicine-in-chronic-kidney-disease 2025-12-30T21:02:50.000Z https://londonkidney.ca/trials/dialytic-clearance-of-tranexamic-acid-prospective-observational-study 2026-04-13T10:52:41.000Z https://londonkidney.ca/trials/iptacopan-in-patients-with-anca-associated-vasculitis 2025-12-30T20:59:15.000Z https://londonkidney.ca/trials/canadian-medical-assessment-of-jinarc-outcomes-registry 2025-12-30T20:59:14.000Z https://londonkidney.ca/trials/a-study-to-evaluate-the-efficacy-and-safety-of-sefaxersen-ro7434656-in-participants-with-primary 2025-12-30T22:54:19.000Z https://londonkidney.ca/trials/a-study-of-mezagitamab-in-adults-with-primary-iga-nephropathy-kidney-condition 2025-12-30T21:00:54.000Z https://londonkidney.ca/trials/a-pilot-study-to-assess-the-safety-and-efficacy-of-alefacept-in-de-novo-kidney-transplant-recipi 2025-12-30T20:59:12.000Z https://londonkidney.ca/trials/prebiotic-therapy-to-improve-outcomes-of-renal-transplant 2026-04-12T16:01:58.000Z https://londonkidney.ca/trials/atacicept-in-multiple-glomerular-diseases-pioneer 2026-04-12T16:02:02.000Z https://londonkidney.ca/trials/phase-2-study-of-alxn2030-in-patients-with-antibody-mediated-rejection-after-kidney-transplantat 2026-04-12T16:04:11.000Z https://londonkidney.ca/trials/exercise-and-cardiac-stunning-during-hd 2025-12-30T21:31:48.000Z https://londonkidney.ca/trials/study-to-evaluate-the-effect-of-balcinrenone-dapagliflozin-in-patients-with-heart-failure-and-im 2026-04-13T10:52:47.000Z https://londonkidney.ca/trials/ckd-specific-telemonitoring-platform-to-minimize-adverse-outcomes-in-high-risk-ckd-patients 2026-04-13T10:52:43.000Z https://londonkidney.ca/trials/outcomes-of-a-higher-vs-lower-hemodialysate-magnesium-concentration-dial-mag-canada 2025-12-30T21:31:47.000Z https://londonkidney.ca/trials/kidney-sodium-content-in-cardiorenal-patients 2026-04-12T16:04:14.000Z https://londonkidney.ca/trials/clinical-characteristics-and-multidisciplinary-care-for-adults-with-tuberous-sclerosis-complex 2025-12-30T21:02:52.000Z https://londonkidney.ca/trials/safety-efficacy-and-tolerability-of-ianalumab-versus-placebo-combination-with-soc-therapy-in-par 2026-04-12T16:04:09.000Z https://londonkidney.ca/trials/a-phase-iii-study-to-investigate-the-efficacy-and-safety-of-baxdrostat-in-combination-with-dapag 2025-12-30T20:54:12.000Z https://londonkidney.ca/trials/randomised-evaluation-of-sodium-dialysate-levels-on-vascular-events 2025-12-30T21:00:48.000Z https://londonkidney.ca/trials/obesity-management-for-kidney-transplantation-ok-transplant-2 2026-04-12T16:04:12.000Z https://londonkidney.ca/trials/study-of-efficacy-and-safety-of-iptacopan-in-patients-with-c3-glomerulopathy 2026-04-12T16:02:05.000Z https://londonkidney.ca/trials/zilebesiran-in-patients-with-hypertension-not-adequately-controlled-and-with-either-established 2026-04-12T16:01:56.000Z https://londonkidney.ca/trials/a-study-to-find-out-if-bi-764198-helps-adults-and-adolescents-with-a-kidney-condition-called-foc 2026-04-12T16:01:57.000Z https://londonkidney.ca/trials/evaluation-of-thiosulfate-enhanced-organ-preservation-solution-in-kidney-transplantation 2026-04-13T10:52:45.000Z https://londonkidney.ca/trials/study-to-investigate-efficacy-safety-and-tolerability-of-zibotentan-dapagliflozin-compared-to-da 2025-12-30T21:02:29.000Z https://londonkidney.ca/trials/study-of-efficacy-and-safety-of-iptacopan-in-participants-with-ic-mpgn 2026-04-13T10:52:44.000Z https://londonkidney.ca/trials/addressing-critical-issues-and-emerging-therapeutics-in-transplantation-for-covid-19-the-treat-c 2026-04-13T10:52:49.000Z https://londonkidney.ca/trials/a-study-to-learn-more-about-the-effects-and-safety-of-felzartamab-infusions-in-adults-with-prima 2026-04-12T16:02:01.000Z https://londonkidney.ca/trials/the-canadian-tuberous-sclerosis-complex-cats-group 2025-12-30T21:02:48.000Z https://londonkidney.ca/trials/screening-for-asymptomatic-coronary-artery-disease-in-kidney-transplant-candidates 2026-04-12T16:04:08.000Z https://londonkidney.ca/trials/urine-cxcl10-monitoring-trial-in-kidney-transplant 2025-12-30T21:02:30.000Z https://londonkidney.ca/trials/atrasentan-in-patients-with-iga-nephropathy 2025-12-30T20:59:11.000Z https://londonkidney.ca/trials/a-study-of-zigakibart-in-adults-with-iga-nephropathy-1 2025-12-30T21:02:28.000Z https://londonkidney.ca/trials/genomic-first-testing-in-chronic-kidney-disease 2026-04-12T16:04:15.000Z https://londonkidney.ca/trials/study-to-evaluate-the-effects-of-av-001-on-hd-induced-brain-injury 2026-04-12T16:02:04.000Z https://londonkidney.ca/trials/a-study-of-tak-755-in-participants-with-congenital-thrombotic-thrombocytopenic-purpura-radamts13 2026-04-12T16:02:00.000Z https://londonkidney.ca/trials/fluid-intake-after-hemodialysis 2026-04-12T16:04:16.000Z https://londonkidney.ca/trials/dial-bicarb-trial-effects-of-a-lower-vs-higher-concentration-of-dialysate-bicarbonate 2026-04-13T10:52:42.000Z https://londonkidney.ca/trials/dialysis-with-expanded-solute-removal 2026-04-12T16:01:59.000Z https://londonkidney.ca/trials/kidney-sodium-functional-imaging 2026-04-12T16:04:13.000Z https://londonkidney.ca/trials/inflammation-reduction-to-prevent-cardiovascular-injury-in-renal-disease-repair 2025-12-30T21:10:48.000Z https://londonkidney.ca/trials/a-study-to-evaluate-the-efficajand-safety-of-frexalimab-brivekimig-or-rilzabrutinib-in-participa 2026-04-13T10:52:48.000Z https://londonkidney.ca/trials/exercise-preconditioning-to-protect-against-dialysis-induced-cardiac-injury 2026-04-13T10:52:40.000Z https://londonkidney.ca/trials/cardiac-tissue-sodium-assessment-in-ckd-patients-using-sodium-mri 2025-12-30T21:10:41.000Z https://londonkidney.ca/trials/a-study-to-evaluate-the-safety-tolerability-and-effects-on-blood-and-urine-markers-of-single-asc 2025-12-30T20:54:14.000Z https://londonkidney.ca/trials/the-effect-of-retatrutide-once-weekly-on-cardiovascular-outcomes-and-kidney-outcomes-in-adults-l 2025-12-30T22:54:05.000Z https://londonkidney.ca/trials/pragmatic-randomised-trial-of-high-or-standard-phosphate-targets-in-end-stage-kidney-disease-pho 2026-04-12T16:04:10.000Z https://londonkidney.ca/trials/a-phase-iii-renal-outcomes-and-cardiovascular-mortality-study-to-investigate-the-efficacy-and-sa 2025-12-30T20:54:15.000Z https://londonkidney.ca/trials/study-of-ravulizumab-in-immunoglobulin-a-nephropathy-igan 2025-12-30T22:54:15.000Z https://londonkidney.ca/trials/identifying-therapeutic-hemodialysis-targets-through-cerebrovascular-reactivity-respiract-2 2025-12-30T21:00:45.000Z https://londonkidney.ca/trials/an-extension-to-assess-the-effect-of-expanded-dialysis-on-patient-reported-symptoms-using-levil 2025-12-30T21:10:45.000Z https://londonkidney.ca/trials/easi-kidney-the-studies-of-heart-kidney-protection-with-bi-690517-in-combination-with-empagliflo 2026-04-12T16:02:03.000Z https://londonkidney.ca/trials/a-study-to-evaluate-the-safety-and-tolerability-of-efgartigimod-ph20-sc-given-by-prefilled-syrin 2025-12-30T22:54:20.000Z https://londonkidney.ca/trials/assessment-of-a-wearable-ultrafiltration-device 2025-12-30T21:10:46.000Z https://londonkidney.ca/trials/transversus-abdominis-plane-catheter-following-kidney-transplantation 2026-04-13T10:52:46.000Z https://londonkidney.ca/trials/a-study-evaluating-persistence-of-the-immune-response-of-the-adjuvanted-respiratory-syncytial-vi 2025-12-30T20:54:11.000Z https://londonkidney.ca/news/london-nephrologists-launch-new-website 2025-12-30T20:54:22.000Z